Authors:
Ciotta, L
De Leo, V
Farina, M
Parfumi, C
La Marca, A
Cianci, A
Citation: L. Ciotta et al., Endocrine and metabolic effects of insulin sensitizers in the treatment ofpatients with polycystic ovary syndrome and hyperinsulinaemia, GYNECOL OBS, 51(1), 2001, pp. 44-50
Authors:
Ciotta, L
Calogero, AE
Farina, M
De Leo, V
La Marca, A
Cianci, A
Citation: L. Ciotta et al., Clinical, endocrine and metabolic effects of acarbose, an alpha-glucosidase inhibitor, in PCOS patients with increased insulin response and normal glucose tolerance, HUM REPR, 16(10), 2001, pp. 2066-2072
Authors:
De Leo, V
la Marca, A
Morgante, G
Lucani, B
Nami, R
Ciotta, L
Cianci, A
Petraglia, F
Citation: V. De Leo et al., Evaluation of plasma levels of renin-aldosterone and blood pressure in women over 35 years treated with new oral contraceptives, CONTRACEPT, 64(3), 2001, pp. 145-148
Authors:
De Leo, V
la Marca, A
Morgante, G
Ciotta, L
Mencaglia, L
Cianci, A
Petraglia, F
Citation: V. De Leo et al., Clomiphene citrate increases insulin-like growth factor binding protein-1 and reduces insulin-like growth factor-I without correcting insulin resistance associated with polycystic ovarian syndrome, HUM REPR, 15(11), 2000, pp. 2302-2305
Authors:
Ciotta, L
De Leo, V
Galvani, F
La Marca, A
Cianci, A
Citation: L. Ciotta et al., Endocrine and metabolic effects of ostreotide, a somatostatin analogue, inlean PCOS patients with either hyperinsulinaemia or lean normoinsulinaemia, HUM REPR, 14(12), 1999, pp. 2951-2958
Authors:
la Marca, A
Morgante, G
Paglia, T
Ciotta, L
Cianci, A
De Leo, V
Citation: A. La Marca et al., Effects of metformin on adrenal steroidogenesis in women with polycystic ovary syndrome, FERT STERIL, 72(6), 1999, pp. 985-989